vs

Side-by-side financial comparison of HARROW, INC. (HROW) and TELOS CORP (TLS). Click either name above to swap in a different company.

HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $46.8M, roughly 1.9× TELOS CORP). HARROW, INC. runs the higher net margin — 7.4% vs -34.9%, a 42.3% gap on every dollar of revenue. On growth, TELOS CORP posted the faster year-over-year revenue change (77.4% vs 33.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $8.0M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 25.7%).

Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.

Telos Corporation is an information technology and cybersecurity company located in Ashburn, Virginia. Telos primarily serves government and enterprise clients, receiving a large number of its contracts from the United States Department of Defense. Customers are primarily military, intelligence and civilian agencies of the US government and NATO allies.

HROW vs TLS — Head-to-Head

Bigger by revenue
HROW
HROW
1.9× larger
HROW
$89.1M
$46.8M
TLS
Growing faster (revenue YoY)
TLS
TLS
+44.1% gap
TLS
77.4%
33.3%
HROW
Higher net margin
HROW
HROW
42.3% more per $
HROW
7.4%
-34.9%
TLS
More free cash flow
HROW
HROW
$120.0K more FCF
HROW
$8.1M
$8.0M
TLS
Faster 2-yr revenue CAGR
HROW
HROW
Annualised
HROW
60.5%
25.7%
TLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HROW
HROW
TLS
TLS
Revenue
$89.1M
$46.8M
Net Profit
$6.6M
$-16.3M
Gross Margin
79.3%
35.0%
Operating Margin
17.5%
-39.6%
Net Margin
7.4%
-34.9%
Revenue YoY
33.3%
77.4%
Net Profit YoY
-2.2%
-74.8%
EPS (diluted)
$0.20
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HROW
HROW
TLS
TLS
Q4 25
$89.1M
$46.8M
Q3 25
$71.6M
$51.4M
Q2 25
$63.7M
$36.0M
Q1 25
$47.8M
$30.6M
Q4 24
$66.8M
$26.4M
Q3 24
$49.3M
$23.8M
Q2 24
$48.9M
$28.5M
Q1 24
$34.6M
$29.6M
Net Profit
HROW
HROW
TLS
TLS
Q4 25
$6.6M
$-16.3M
Q3 25
$1.0M
$-2.1M
Q2 25
$5.0M
$-9.5M
Q1 25
$-17.8M
$-8.6M
Q4 24
$6.8M
$-9.3M
Q3 24
$-4.2M
$-28.1M
Q2 24
$-6.5M
$-7.8M
Q1 24
$-13.6M
$-7.4M
Gross Margin
HROW
HROW
TLS
TLS
Q4 25
79.3%
35.0%
Q3 25
75.3%
39.9%
Q2 25
74.5%
33.2%
Q1 25
67.5%
39.8%
Q4 24
78.8%
40.3%
Q3 24
75.6%
13.2%
Q2 24
74.4%
34.1%
Q1 24
69.5%
37.0%
Operating Margin
HROW
HROW
TLS
TLS
Q4 25
17.5%
-39.6%
Q3 25
20.6%
-4.8%
Q2 25
17.9%
-27.5%
Q1 25
-23.5%
-29.5%
Q4 24
19.3%
-37.6%
Q3 24
2.7%
-121.4%
Q2 24
3.1%
-30.3%
Q1 24
-20.0%
-28.5%
Net Margin
HROW
HROW
TLS
TLS
Q4 25
7.4%
-34.9%
Q3 25
1.4%
-4.1%
Q2 25
7.8%
-26.5%
Q1 25
-37.2%
-28.1%
Q4 24
10.1%
-35.4%
Q3 24
-8.6%
-118.0%
Q2 24
-13.2%
-27.2%
Q1 24
-39.2%
-24.9%
EPS (diluted)
HROW
HROW
TLS
TLS
Q4 25
$0.20
$-0.22
Q3 25
$0.03
$-0.03
Q2 25
$0.13
$-0.13
Q1 25
$-0.50
$-0.12
Q4 24
$0.19
$-0.13
Q3 24
$-0.12
$-0.39
Q2 24
$-0.18
$-0.11
Q1 24
$-0.38
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HROW
HROW
TLS
TLS
Cash + ST InvestmentsLiquidity on hand
$72.9M
$53.2M
Total DebtLower is stronger
$250.0M
Stockholders' EquityBook value
$52.4M
$96.0M
Total Assets
$399.5M
$139.9M
Debt / EquityLower = less leverage
4.77×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HROW
HROW
TLS
TLS
Q4 25
$72.9M
$53.2M
Q3 25
$74.3M
$59.0M
Q2 25
$53.0M
$57.0M
Q1 25
$66.7M
$57.8M
Q4 24
$47.2M
$54.6M
Q3 24
$72.6M
$69.8M
Q2 24
$71.0M
$80.1M
Q1 24
$76.0M
$93.9M
Total Debt
HROW
HROW
TLS
TLS
Q4 25
$250.0M
Q3 25
$347.2M
Q2 25
$250.6M
Q1 25
$256.9M
Q4 24
$262.7M
Q3 24
$230.7M
Q2 24
$236.3M
Q1 24
$243.4M
Stockholders' Equity
HROW
HROW
TLS
TLS
Q4 25
$52.4M
$96.0M
Q3 25
$47.0M
$119.7M
Q2 25
$49.7M
$118.4M
Q1 25
$56.5M
$126.1M
Q4 24
$69.7M
$127.1M
Q3 24
$58.0M
$129.5M
Q2 24
$58.5M
$149.1M
Q1 24
$60.6M
$154.4M
Total Assets
HROW
HROW
TLS
TLS
Q4 25
$399.5M
$139.9M
Q3 25
$363.1M
$164.3M
Q2 25
$345.0M
$165.0M
Q1 25
$364.2M
$158.1M
Q4 24
$389.0M
$158.2M
Q3 24
$351.5M
$166.3M
Q2 24
$306.6M
$182.4M
Q1 24
$295.5M
$195.4M
Debt / Equity
HROW
HROW
TLS
TLS
Q4 25
4.77×
Q3 25
7.39×
Q2 25
5.05×
Q1 25
4.55×
Q4 24
3.77×
Q3 24
3.98×
Q2 24
4.04×
Q1 24
4.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HROW
HROW
TLS
TLS
Operating Cash FlowLast quarter
$8.4M
$8.0M
Free Cash FlowOCF − Capex
$8.1M
$8.0M
FCF MarginFCF / Revenue
9.1%
17.0%
Capex IntensityCapex / Revenue
0.4%
0.1%
Cash ConversionOCF / Net Profit
1.27×
TTM Free Cash FlowTrailing 4 quarters
$43.0M
$29.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HROW
HROW
TLS
TLS
Q4 25
$8.4M
$8.0M
Q3 25
$16.6M
$9.1M
Q2 25
$-803.0K
$7.0M
Q1 25
$19.7M
$6.1M
Q4 24
$-17.8M
$-10.5M
Q3 24
$3.0M
$-7.1M
Q2 24
$-2.7M
$-8.0M
Q1 24
$-4.6M
$-350.0K
Free Cash Flow
HROW
HROW
TLS
TLS
Q4 25
$8.1M
$8.0M
Q3 25
$16.4M
$8.7M
Q2 25
$-969.0K
$6.8M
Q1 25
$19.5M
$6.0M
Q4 24
$-18.3M
$-12.4M
Q3 24
$2.3M
$-7.1M
Q2 24
$-3.1M
$-8.2M
Q1 24
$-4.7M
$-447.0K
FCF Margin
HROW
HROW
TLS
TLS
Q4 25
9.1%
17.0%
Q3 25
22.9%
16.9%
Q2 25
-1.5%
19.0%
Q1 25
40.8%
19.5%
Q4 24
-27.4%
-47.0%
Q3 24
4.8%
-30.0%
Q2 24
-6.3%
-28.9%
Q1 24
-13.6%
-1.5%
Capex Intensity
HROW
HROW
TLS
TLS
Q4 25
0.4%
0.1%
Q3 25
0.3%
0.9%
Q2 25
0.3%
0.4%
Q1 25
0.4%
0.4%
Q4 24
0.8%
7.1%
Q3 24
1.2%
0.2%
Q2 24
0.7%
0.8%
Q1 24
0.3%
0.3%
Cash Conversion
HROW
HROW
TLS
TLS
Q4 25
1.27×
Q3 25
16.26×
Q2 25
-0.16×
Q1 25
Q4 24
-2.62×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HROW
HROW

Segment breakdown not available.

TLS
TLS

Security Solutions Segment$44.8M96%
Secure Networks Segment$1.9M4%

Related Comparisons